Search Results

We validate them using TCGA PanCanAtlas datasets, established driver prediction algorithms and custom

September 2022 Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy "Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive the GPCR agonist neurotensin induced rapid activation of Src family of tyrosine kinases (SFKs) within PANC interfering RNA (siRNA)-mediated knockdown of YES1 and transfection of epitogue-tagged YAP mutants in PANC

A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent

GPCRs in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled

The exciting news is that this Symposium will be a trainee day with a career panel. Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential

Pancreatic ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed Jillian G for drug repurposing to prevent and treat murine colitis and sepsis GPCRs in Oncology and Immunology Pancreatic

journey is often compared to a rollercoaster, and I found this to be especially true during the COVID-19 pandemic

Receptor determinants for ß-arrestin functional specificity at C-X-C chemokine receptor 5 (CXCR5) Panjamaporn

Industry News Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform GPCR Safety Panels

Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand effects in pancreatic

microenvironment in cancer progression and therapy Agonists of galanin subtype 2 receptor may prevent pancreatic

orientation using a neurotensin receptor 1 peptide Illuminating the neuropeptide Y4 receptor and its ligand pancreatic

., Panova, O., Hilger, D., Casiraghi, M., He, F., Maul, L., Gmeiner, P., Kobilka, B.

exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic

Computational modelling of dynamic cAMP responses to GPCR agonists for exploration of GLP-1R ligand effects in pancreatic

Additionally, we are having a Panel Discussion on Publishing in Academia with Drs.

Cardiology, Endocrinology, and Taste The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic

from January 15th to 21st, 2024 Adhesion GPCRs The adhesion GPCR GPR116/ADGRF5 has a dual function in pancreatic

A panel of top experts will be discussing this topic in a roundtable, starting at 10:00 AM EST.

A panel of top experts will discuss in a roundtable starting at 10 AM EST. Oncology and Immunology Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic

A panel of top experts will discuss in a roundtable starting at 10 AM EST. PC12 cells GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic

We've gathered a panel of top experts for a roundtable discussion starting at 10 a.m. EST.

The symposium will feature a trainee day with a career panel. Remember to subscribe to Dr.

This year's symposium will feature a trainee day with a career panel.

We will be hosting a career panel (more on our panelists soon)!

Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with Industry News Orion Biotechnology will be participating in a panel discussion at the LSX World Congress

polycystic kidney disease GPCRs in Oncology and Immunology Purinergic GPCR-integrin interactions drive pancreatic

startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic